Artificial Intelligence in Cardiovascular Imaging: JACC State-of-the-Art Review
Data science is likely to lead to major changes in cardiovascular imaging. Problems with
timing, efficiency, and missed diagnoses occur at all stages of the imaging chain. The …
timing, efficiency, and missed diagnoses occur at all stages of the imaging chain. The …
The influence of drug-like concepts on decision-making in medicinal chemistry
PD Leeson, B Springthorpe - Nature reviews Drug discovery, 2007 - nature.com
The application of guidelines linked to the concept of drug-likeness, such as the'rule of five',
has gained wide acceptance as an approach to reduce attrition in drug discovery and …
has gained wide acceptance as an approach to reduce attrition in drug discovery and …
The role of ligand efficiency metrics in drug discovery
The judicious application of ligand or binding efficiency metrics, which quantify the molecular
properties required to obtain binding affinity for a drug target, is gaining traction in the …
properties required to obtain binding affinity for a drug target, is gaining traction in the …
The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions
UK Biobank is a population-based cohort of half a million participants aged 40–69 years
recruited between 2006 and 2010. In 2014, UK Biobank started the world’s largest multi-modal …
recruited between 2006 and 2010. In 2014, UK Biobank started the world’s largest multi-modal …
A comparison of physiochemical property profiles of development and marketed oral drugs
The process of drug discovery applies rigorous selection pressures. Marketed oral drugs
will generally possess favorable physiochemical properties with respect to absorption, …
will generally possess favorable physiochemical properties with respect to absorption, …
Molecular property design: does everyone get it?
The principles of molecular property optimization in drug design have been understood for
decades, yet much drug discovery activity today is conducted at the periphery of historical …
decades, yet much drug discovery activity today is conducted at the periphery of historical …
An analysis of the attrition of drug candidates from four major pharmaceutical companies
The pharmaceutical industry remains under huge pressure to address the high attrition rates
in drug development. Attempts to reduce the number of efficacy- and safety-related failures …
in drug development. Attempts to reduce the number of efficacy- and safety-related failures …
Time-related differences in the physical property profiles of oral drugs
Comparisons of the calculated physicochemical properties of oral drugs launched prior to
1983 (864 drugs) and between 1983 and 2002 (329 drugs) show that mean values of …
1983 (864 drugs) and between 1983 and 2002 (329 drugs) show that mean values of …
Is there a difference between leads and drugs? A historical perspective
To be considered for further development, lead structures should display the following
properties: (1) simple chemical features, amenable for chemistry optimization; (2) membership to …
properties: (1) simple chemical features, amenable for chemistry optimization; (2) membership to …
The design of leadlike combinatorial libraries
The optimization of low‐potency leads into drugs is often accompanied by an increase in
molecular weight (M r ) and lipophilicity, as a consequence of affinity enhancement. Hits with …
molecular weight (M r ) and lipophilicity, as a consequence of affinity enhancement. Hits with …